Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Pertusati

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|August 7, 2019
Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of <i>N</i>-Acetylmannosamine 6-PhosphateChiara Morozzi, Jana Sedláková, Michaela Serpi, et al.
Journal of Molecular Structure|February 5, 2024
Synthesis, molecular docking and antibacterial activity of an oxadiazole-based lipoteichoic acid inhibitor and its metabolitesMichaela Serpi, Fabrizio Pertusati, Chiara Morozzi, et al.
The Journal of Antimicrobial Chemotherapy|July 21, 2020
Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobialsFabrizio Pertusati, Elisa Pileggi, Jennifer Richards, et al.
The Journal of Organic Chemistry|May 9, 2014
Synthesis of an apionucleoside family and discovery of a prodrug with anti-HIV activityKiran S Toti, Marco Derudas, Fabrizio Pertusati, et al.
Bioorganic & Medicinal Chemistry|April 3, 2014
ProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agentsChristopher McGuigan, Marco Derudas, Blanka Gonczy, et al.
European Journal of Medicinal Chemistry|November 2, 2013
Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosidesChristopher McGuigan, Claire Bourdin, Marco Derudas, et al.
Journal of Inherited Metabolic Disease|December 28, 2020
The nucleotide prodrug CERC-913 improves mtDNA content in primary hepatocytes from DGUOK-deficient ratsMark A Vanden Avond, Hui Meng, Margaret J Beatka, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|August 7, 2019
Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of <i>N</i>-Acetylmannosamine 6-PhosphateChiara Morozzi, Jana Sedláková, Michaela Serpi, et al.
Journal of Molecular Structure|February 5, 2024
Synthesis, molecular docking and antibacterial activity of an oxadiazole-based lipoteichoic acid inhibitor and its metabolitesMichaela Serpi, Fabrizio Pertusati, Chiara Morozzi, et al.
The Journal of Antimicrobial Chemotherapy|July 21, 2020
Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobialsFabrizio Pertusati, Elisa Pileggi, Jennifer Richards, et al.
The Journal of Organic Chemistry|May 9, 2014
Synthesis of an apionucleoside family and discovery of a prodrug with anti-HIV activityKiran S Toti, Marco Derudas, Fabrizio Pertusati, et al.
Bioorganic & Medicinal Chemistry|April 3, 2014
ProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agentsChristopher McGuigan, Marco Derudas, Blanka Gonczy, et al.
European Journal of Medicinal Chemistry|November 2, 2013
Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosidesChristopher McGuigan, Claire Bourdin, Marco Derudas, et al.
Journal of Inherited Metabolic Disease|December 28, 2020
The nucleotide prodrug CERC-913 improves mtDNA content in primary hepatocytes from DGUOK-deficient ratsMark A Vanden Avond, Hui Meng, Margaret J Beatka, et al.
Pageof 4